What is Gujarat Themis Biosyn Ltd (GUJTHEM) share price return in the past 10 years?

Gujarat Themis Biosyn Ltd share price has appreciated 50.3% annually (CAGR) over the past ten years.

What is the share price of Gujarat Themis Biosyn Ltd (GUJTHEM)?

Company share prices are keep on changing according to the market conditions. The current trading price of Gujarat Themis Biosyn Ltd (GUJTHEM) on 04-Jun-2026 16:59:59 at 16:59 is 411.55.

What is the P/E ratio of Gujarat Themis Biosyn?

The latest standalone P/E ratio of Gujarat Themis Biosyn as of 04-Jun-2026 is 96.06.

What is the P/B ratio of Gujarat Themis Biosyn Ltd (GUJTHEM)?

The latest standalone P/B ratio of Gujarat Themis Biosyn Ltd (GUJTHEM) as of 04-Jun-2026 is 15.58.

What is the 52-week high and low of Gujarat Themis Biosyn Ltd (GUJTHEM)?

The 52-week high of Gujarat Themis Biosyn Ltd (GUJTHEM) is Rs. 479.45 and the 52-week low is Rs. 225.75.

What is the TTM revenue of Gujarat Themis Biosyn Ltd (GUJTHEM)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gujarat Themis Biosyn is Rs. 165.82 (Cr.).

Gujarat Themis Biosyn Ltd (GUJTHEM) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Gujarat Themis Biosyn Ltd (GUJTHEM)
Brand: Gujarat Themis Biosyn

Gujarat Themis Biosyn Ltd (GUJTHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506879 NSE: GUJTHEM Pharmaceuticals & Drugs | Small Cap | Guj. Themis Biosyn Share Price

Gujarat Themis Biosyn Ltd (GUJTHEM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506879 NSE: GUJTHEM Pharmaceuticals & Drugs | Small Cap | Guj. Themis Biosyn Share Price

Key Metrics

Valuation Multiples

Market Cap

₹4,484 Cr.

Current Price

₹411.6

52-Week Low / High

₹226 / 479

TTM EPS

₹4.3

TTM Sales

₹166 Cr.

Book Value per Share

₹26.4

P/E Ratio

96.06

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

15.58

Higher than its 5-year historical median

Price to Sales (P/S)

27.04

Higher than its 5-year historical median

EV/EBITDA

59.50

Higher than its 5-year historical median

Dividend Yield

0.24%

Profitability Efficiency

Return on Equity (ROE)

21.69%

Outperforms industry median

Return on Capital Employed (ROCE)

27.48%

Outperforms industry median

Return on Assets (ROA)

17.44%

Operating Profit Margin

45.7%

Net Profit Margin

32.34%

Gross Profit Margin

47%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-11.2%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-12.56%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-17.56%

Asset Quality

Promoter Holding

70.86%

Pledged shares (%) of Promoter's holding (%)

5.44%

Reserves

₹277 Cr.

Equity

₹10.9 Cr.

Face Value

₹1

All Time Low / High

₹0.20 / 479.45

Gujarat Themis Biosyn stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Overvalued

Check Valuation charts

Price Trend

Strong

Check Price chart

Q.1 Is Gujarat Themis Biosyn Ltd a good quality company?

Gujarat Themis Biosyn Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Gujarat Themis Biosyn Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Gujarat Themis Biosyn Ltd vs industry peers?

Gujarat Themis Biosyn Ltd revenue CAGR is 12.12%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Gujarat Themis Biosyn Ltd?

Promoters hold 70.86% of the Gujarat Themis Biosyn Ltd, with 5.44% of their stake pledged, indicating low pledge risk.

Q.1 Stock return of Gujarat Themis Biosyn Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 45.9% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	80.4%	54.7%	42.2%	44.9%	86%	67.9%	67.9%	61.5%	45.4%	27.5%	-
Value Creation Index ⓘ	4.7	2.9	2.0	2.2	5.1	3.9	3.9	3.4	2.2	1.0	-
Growth Parameters ⓘ
Sales ⓘ	32.6	35.7	38.8	41.1	85.1	90.6	115	148	170	151	166
Sales YoY Gr.	-	9.4%	8.7%	5.8%	107.4%	6.4%	26.8%	29.2%	14.4%	-11.2%	-
Adj EPS ⓘ	0.4	0.4	0.4	0.6	2.2	2.8	4	5.3	5.4	4.5	4.3
YoY Gr.	-	-4.8%	-10%	61.1%	274.1%	27.7%	44.4%	33%	2.1%	-17.7%	-
BVPS (₹) ⓘ	0.4	0.8	1.1	1.7	3.9	6.4	9.5	13.7	18.5	22.8	26.4
Adj Net Profit ⓘ	4.6	4.4	3.9	6.4	23.7	30.2	43.6	58	59.2	48.7	47
Cash Flow from Ops. ⓘ	3.9	2.8	5.6	0.7	0.6	10.5	40.3	39.5	64.2	91	-
Debt/CF from Ops. ⓘ	0.9	1.4	0.1	8.8	12.9	0.3	0	0	0	0.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	18.5%	12.1%	9.5%	-11.2%
Adj EPS ⓘ	30.1%	15.6%	3.8%	-17.7%
BVPSⓘ	59%	42.6%	34%	23.3%
Share Price	50.3%	61.2%	60.3%	24.8%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	302.7	72.5	38.1	41.6	78	53.8	50.4	45.9	33.8	21.7	17.4
Op. Profit Mgn % ⓘ	18.5	17	16.1	17.9	37.4	44.5	50.5	49.6	46.4	45.7	45.6
Net Profit Mgn % ⓘ	14.2	12.2	10	15.5	27.8	33.3	38	39.1	34.9	32.3	28.1
Debt to Equity ⓘ	0.9	0.5	0.1	0.3	0.2	0	0	0	0	0.1	0.4
Working Cap Days ⓘ	55	78	73	92	144	204	226	267	245	222	74
Cash Conv. Cycle ⓘ	-47	-26	-22	-19	27	54	62	47	24	26	14

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	33	36	39	41	85	91	115	148	170	151
Operating Expenses ⓘ +	27	30	33	34	53	50	57	75	91	82
Manufacturing Costs	21	23	25	26	34	26	31	37	40	40
Material Costs	0	1	2	1	11	15	16	26	36	23
Employee Cost	4	4	4	5	6	7	7	8	10	11
Other Costs ⓘ	1	1	2	2	2	2	3	4	5	8
Operating Profit ⓘ	6	6	6	7	32	40	58	74	79	69
Operating Profit Margin (%)	18.5%	16.9%	16.1%	17.9%	37.4%	44.5%	50.5%	49.6%	46.4%	45.7%
Other Income ⓘ +	0	0	0	2	2	3	4	7	4	2
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	1	1	1	0	0	0
Depreciation ⓘ	1	1	1	1	1	2	2	3	4	5
Profit Before Tax ⓘ	5	5	5	8	31	41	59	77	79	66
Tax ⓘ	0	1	1	2	8	11	15	19	20	17
Profit After Tax	5	4	4	6	24	30	44	58	59	49
PAT Margin (%)	14.2%	12.3%	10.0%	15.6%	27.8%	33.3%	38.0%	39.1%	34.8%	32.3%
Adjusted EPS (₹)	0.4	0.4	0.4	0.6	2.2	2.8	4.0	5.3	5.4	4.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	10.10%	0%	36.60%	13.50%	12.30%	15%

Valuation of Guj. Themis Biosyn - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	4	8	12	19	42	70	103	149	201	248
Share Capital ⓘ	7	7	7	7	7	7	7	7	7	11
Reserves ⓘ	-3	1	5	11	35	63	96	142	194	237
Debt +	1	2	0	0	3	0	0	0	0	30
Long Term Debt	1	1	0	0	3	0	0	0	0	30
Short Term Debt	0	1	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6	7	6	6	7	4	7	10	10	15
Others Liabilities ⓘ	4	4	3	9	18	25	27	28	30	25
Total Liabilities ⓘ	15	21	20	33	71	98	137	187	241	318
Fixed Assets
Net Fixed Assets ⓘ +	9	11	11	15	17	19	19	33	38	41
Gross Block	42	12	13	18	22	26	28	44	51	59
Accumulated Depreciation	32	1	2	3	5	7	9	11	13	18
CWIP ⓘ	0	0	0	1	0	2	13	21	91	184
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0	1	0	0	6	6	12	15	3	5
Trade Receivables	2	7	3	6	20	15	25	18	27	31
Cash Equivalents	0	0	4	2	2	28	12	9	8	13
Others Assets ⓘ	2	3	2	9	25	29	56	92	73	43
Total Assets ⓘ	15	21	20	33	71	98	137	187	241	318

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	4	3	6	1	1	11	40	39	64	91
PBT ⓘ	5	5	5	8	31	41	59	77	79	66
Adjustment ⓘ	2	1	1	-4	1	-0	0	-2	0	5
Changes in Working Capital ⓘ	-2	-3	-0	-2	-24	-20	-4	-15	4	37
Tax Paid ⓘ	-1	-1	-1	-1	-7	-10	-15	-20	-20	-16
Cash Flow From Investing Activity ⓘ +	-1	-3	-1	-6	-3	-2	-30	-20	-55	-112
Capex	-1	-3	-1	-6	-3	-3	-14	-24	-75	-116
Net Investments	-0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	1	-16	3	19	4
Cash Flow From Financing Activity ⓘ +	-3	-0	-4	5	2	-5	-14	-13	-9	26
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-4	0	0	0	0	0	0	0	0	30
Interest Paid ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	-2	-10	-12	-7	-2
Others ⓘ	1	0	-4	5	2	-2	-4	-1	-2	-1
Net Cash Flow ⓘ	-0	0	1	0	-0	3	-4	6	0	5

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	302.71	72.63	38.06	41.85	77.99	53.82	50.35	45.92	33.76	21.69
ROCE (%)	80.38	54.67	42.22	44.88	85.96	67.89	67.91	61.51	45.4	27.48
Asset Turnover Ratio	2.22	1.98	1.85	1.54	1.64	1.07	0.98	0.92	0.79	0.54
PAT to CFO Conversion(x)	0.8	0.75	1.5	0.17	0.04	0.37	0.91	0.67	1.08	1.86
Working Capital Days
Receivable Days	25.40	46.80	45.70	37.90	55.80	70.40	63.30	52.90	48.30	70.50
Inventory Days	4.20	4.70	4.60	3.60	13.70	24.30	28.10	32.30	19.30	10.10
Payable Days	0	2,000.10	1,308.80	2,103.60	215.30	132.50	115.10	114.40	99.40	193

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

3.30

0.00

3.30

4.49

5.44

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gujarat Themis Biosyn Ltd FAQs

The current trading price of Guj. Themis Biosyn on 04-Jun-2026 16:59 is ₹411.6.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Guj. Themis Biosyn stood at ₹4,484.5 Cr

The latest P/E ratio of Guj. Themis Biosyn as of 03-Jun-2026 is 96.06.

The latest P/B ratio of Guj. Themis Biosyn as of 03-Jun-2026 is 15.58.

The 52-week high of Guj. Themis Biosyn is ₹479.4 and the 52-week low is ₹225.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Guj. Themis Biosyn is ₹166 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gujarat Themis Biosyn Ltd is a good quality company.

The key valuation ratios of Gujarat Themis Biosyn Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Gujarat Themis Biosyn Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd, established in 1981, is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $ 40 million. It has EDMFs, available and WHO approved plants.

The company has world-wide exports to satisfied customers, having customised facility for all products.

The companyâ€™s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.

Kopran alongwith Cadila Healthcare Ltd., Lyka Labs Ltd., Themis Chemicals Ltd. and Anant & Co., formed Pharmaceutical Business Group (India) Ltd. in 1990.PBG acquired Gujarat Themis Biosyn Ltd (GTBL) as a sick company from BIFR in collaboration with Yuhan Corporation, South Korea and became Indiaâ€™s first producer of Rifampicin.Yuhan has provided technology for Rifampicin from fermentation and invested in equity also.

Business area of the company

Pharmaceuticals & Drugs

Gujarat Themis Biosyn Ltd (GUJTHEM)

Gujarat Themis Biosyn Ltd (GUJTHEM)

Gujarat Themis Biosyn stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Guj. Themis Biosyn - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gujarat Themis Biosyn Ltd FAQs

About Gujarat Themis Biosyn Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Gujarat Themis Biosyn Ltd (GUJTHEM)

Gujarat Themis Biosyn Ltd (GUJTHEM)

Gujarat Themis Biosyn stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Guj. Themis Biosyn - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gujarat Themis Biosyn Ltd FAQs

What is the share price of Guj. Themis Biosyn?

What is the market cap of Guj. Themis Biosyn?

What is the P/E ratio of Guj. Themis Biosyn?

What is the P/B ratio of Guj. Themis Biosyn?

What is the 52-week high and low of Guj. Themis Biosyn?

What is the TTM revenue of Guj. Themis Biosyn?

Is Gujarat Themis Biosyn Ltd a good quality company?

Is Gujarat Themis Biosyn Ltd undervalued or overvalued?

Is Gujarat Themis Biosyn Ltd a good buy now?

About Gujarat Themis Biosyn Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.